DGAP-PVR: PSI Aktiengesellschaft für Produkte und Systeme

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 21, 2016 at 5:00 AM

DGAP-PVR: PSI Aktiengesellschaft für Produkte und Systeme der Informationstechnologie: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

PSI Aktiengesellschaft für Produkte und Systeme der Informationstechnologie 21.07.2016 10:43 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of Major Holdings 1. Details of issuer PSI Aktiengesellschaft für Produkte und Systeme der Informationstechnologie Dircksenstraße 42-44 10178 Berlin Germany 2. Reason for notification Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights X Other reason: Notification of voting rights pursuant to sec. 41 para. 4g WpHG 3. Details of person subject to the notification obligation Name: City and country of registered office: Baden-Württembergische Versorgungsanstalt für Tübingen Germany Ärzte, Zahnärzte und Tierärzte 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached 02 Jul 2016 6. Total positions % of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 5.23 % 0 % 5.23 % 15697366 ing situat- ion Previo- 0.00 % 0 % 0 % / us notifi- cation 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in % direct indirect direct indirect (Sec. 21 WpHG) (Sec. 22 WpHG) (Sec. 21 WpHG) (Sec. 22 WpHG) DE000A0Z1JH9 820321 5.23 % % Total 820321 5.23 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % % Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total % 8. Information in relation to the person subject to the notification obligation X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights % of voting rights Total of both (if (if at least held 3% through instruments (if at least held 5% or more) at least held 5% or more) or more) 9. In case of proxy voting according to Sec. 22 para. 3 WpHG Date of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: Aufgrund der erneuten Gesetzesänderung durch das 1. FiMaNoG ist die Baden-Württembergische Versorgungsanstalt für Ärzte, Zahnärzte und Tierärzte nach § 1 Abs. 3 und 41 Abs. 4g WpHG als Anleger eines offenen Spezialinvestmentvermögens verpflichtet, ihren zum Stichtag 2.7.2016 gehaltenen Stimmrechtsanteil wieder offenzulegen. 21.07.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: PSI Aktiengesellschaft für Produkte und Systeme der Informationstechnologie Dircksenstraße 42-44 10178 Berlin Germany Internet: www.psi.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...